Adapting RDAD for DS
CareFit DS/AD
Adapting the RDAD Intervention for Individuals With Down Syndrome Phase 3- Pilot Test
2 other identifiers
interventional
40
1 country
1
Brief Summary
The goal of this clinical trial is to observe feasibility and initial efficacy of a remotely delivered exercise and dementia caregiving intervention in older adults with Down syndrome and their caregivers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 11, 2026
CompletedFirst Posted
Study publicly available on registry
February 23, 2026
CompletedStudy Start
First participant enrolled
March 31, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 31, 2026
May 6, 2026
May 1, 2026
4 months
February 11, 2026
May 5, 2026
Conditions
Outcome Measures
Primary Outcomes (5)
Feasibility: Participant Recruitment
Number of participants enrolled divided by number eligible on questionnaire
Baseline
Feasibility: Recruitment Rate
Number of participants enrolled per month of active recruitment
Baseline
Feasibility: Participant retention
Calculated as number of participants completing the intervention divided by the number who initiate the intervention multiplied by 100
Baseline to Week 12
Feasibility: Session Attendance
Calculated as the percentage of sessions attended across 12 weeks.
Across 12 week intervention
Feasibility: Participant Safety
Will be expressed as the total number of self-reported adverse events.
Across 12 week intervention
Secondary Outcomes (23)
Participant Sedentary Time
Baseline and Week 12
Participant Physical Activity
Baseline and Week 12
Participant Five Times Sit to Stand
Baseline and Week 12
Participant Timed Up and Go
Baseline and Week 12
Participant 2 Minute Step Test
Baseline and Week 12
- +18 more secondary outcomes
Other Outcomes (2)
Physiological Stress
Baseline and Week 12
Intervention Acceptability
Week 12
Study Arms (1)
Remote Exercise and Caregiver Education
EXPERIMENTALSingle Arm with active intervention for remote exercise and caregiver education sessions
Interventions
Participants will take part in thrice weekly exercise sessions using pre-recorded videos designed for older adults with Down syndrome. Participants will join video call and follow along with the video. A staff member familiar with the population will be on the call to provide modifications, encouragement and ensure participant safety.
Caregivers will join a once-weekly education session held via video call and led by a trained staff member. Education content will include how to support and manage challenging behaviors of older adults with Down syndrome who may be experiencing Alzheimer's disease-related symptoms.
Eligibility Criteria
You may qualify if:
- Age \>35 yrs. with a diagnosis of DS as self-reported or reported by caregiver. This age range was selected as cognitive decline related to AD is observed at age \~31 in adults with DS.
- Sufficient functional ability to understand directions, communicate preferences, wants, and needs through spoken language.
- Living at home or in a supported living environment with a parent/caregiver who agrees to serve as a study partner.
- Self-reported ability to participate in physical activity.
You may not qualify if:
- Unable to participate in moderate-to-vigorous physical activity.
- Self-reported, cardiovascular, metabolic or renal disease and/or signs or symptoms.
- Age ≥18 yrs.
- Reports being a primary caregiver of an adult with DS.
- English speaking.
- Self-reported ability to participate in physical activity.
- Unable to participate in moderate PA, i.e., brisk walking.
- Self-reported, cardiovascular, metabolic or renal disease and/or signs or symptoms.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 11, 2026
First Posted
February 23, 2026
Study Start
March 31, 2026
Primary Completion (Estimated)
July 31, 2026
Study Completion (Estimated)
July 31, 2026
Last Updated
May 6, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share